Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Machine Learning-Based Decision Model for Optimal Adjuvant Therapy in Primary Gastric Neuroendocrine Carcinoma: a National Real-World Evidence Study

NCT06663852 is registered in ClinicalTrials.gov with Chang-Ming Huang, Prof. as lead sponsor.

NCT NCT06663852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06663852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Machine Learning-Based Decision Model for Optimal Adjuvant Therapy in Primary Gastric Neuroendocrine Carcinoma: a National Real-World Evidence Study
Lead sponsor
Chang-Ming Huang, Prof.
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
June 30, 2024
Enrollment
1,505 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric neuroendocrine carcinoma (g-nec), machine learning, postoperative adjuvant therapy for g-nec, survival outcomes